Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Rev Allergy Immunol. 2008 Feb;34(1):36-9. doi: 10.1007/s12016-007-8029-y.

Anti-CCP2 antibodies: an overview and perspective of the diagnostic abilities of this serological marker for early rheumatoid arthritis.

Author information

1
Department of Biomolecular Chemistry, Radboud University Nijmegen, Nijmegen, The Netherlands. w.vanvenrooij@ncmls.ru.nl

Abstract

The literature of the last 4 years confirms that the anti-CCP2 test is a very useful marker for the early and specific diagnosis of rheumatoid arthritis (RA). The anti-CCP2 test is very specific for RA (95-99%) and has sensitivity comparable to that of the rheumatoid factor (70-75%). The antibodies can be detected very early in the disease and can be used as an indicator for the progression and prognosis of RA. In this review, these interesting properties and some future possibilities of this diagnostic test are discussed.

PMID:
18270856
PMCID:
PMC2243253
DOI:
10.1007/s12016-007-8029-y
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center